» Articles » PMID: 33672474

Transcriptome Analysis of the Anti-TGFβ Effect of Fruit Extract and Schisandrin B in A7r5 Vascular Smooth Muscle Cells

Overview
Journal Life (Basel)
Specialty Biology
Date 2021 Mar 6
PMID 33672474
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

fruit extract (SCE) has been used as a traditional medicine for treating vascular diseases. However, little is known about how SCE and schisandrin B (SchB) affect transcriptional output-a crucial factor for shaping the fibrotic responses of the transforming growth factor β (TGFβ) signaling pathways in in vascular smooth muscle cells (VSMC). In this study, to assess the pharmacological effect of SCE and SchB on TGFβ-induced transcriptional output, we performed DNA microarray experiments in A7r5 VSMCs. We found that TGFβ induced distinctive changes in the gene expression profile and that these changes were considerably reversed by SCE and SchB. Gene Set Enrichment Analysis (GSEA) with Hallmark signature suggested that SCE or SchB inhibits a range of fibrosis-associated biological processes, including inflammation, cell proliferation and migration. With our VSMC-specific transcriptional interactome network, master regulator analysis identified crucial transcription factors that regulate the expression of SCE- and SchB-effective genes (i.e., TGFβ-reactive genes whose expression are reversed by SCE and SchB). Our results provide novel perspective and insight into understanding the pharmacological action of SCE and SchB at the transcriptome level and will support further investigations to develop multitargeted strategies for the treatment of vascular fibrosis.

Citing Articles

Schisandrin B attenuates bleomycin-induced pulmonary fibrosis in mice through AKT-mTOR pathway.

Yang J, Zhou D, Hu J, Yang D, Cai Y, Lu Q Sarcoidosis Vasc Diffuse Lung Dis. 2024; 41(3):e2024034.

PMID: 39315985 PMC: 11472673. DOI: 10.36141/svdld.v41i3.12728.


The Therapeutic Mechanism of Schisandrol A and Its Metabolites on Pulmonary Fibrosis Based on Plasma Metabonomics and Network Analysis.

Qiaolongbatu X, Zhao W, Huang X, Qian F, Yang X, Wu J Drug Des Devel Ther. 2023; 17:477-496.

PMID: 36814892 PMC: 9939797. DOI: 10.2147/DDDT.S391503.


A Novel Angiotensin I-Converting Enzyme Inhibitory Peptide Derived From Goat Milk Casein Hydrolysate Modulates Angiotensin II-Stimulated Effects on Vascular Smooth Muscle Cells.

Qiao Z, Wang J, He Z, Pan L, Feng K, Peng X Front Nutr. 2022; 9:878768.

PMID: 35479750 PMC: 9037752. DOI: 10.3389/fnut.2022.878768.


Protective effects of Schisandrin B against D-GalN-induced cell apoptosis in human hepatocyte (L02) cells via modulating Bcl-2 and Bax.

Hu Y, Li H, Li R, Tian Y, Wu Z Bioengineered. 2021; 12(1):7205-7214.

PMID: 34546847 PMC: 8806808. DOI: 10.1080/21655979.2021.1979863.


Optimization of Fermentation Process of Pomegranate Peel and and the Biological Activities of Fermentation Broth: Antioxidant Activity and Protective Effect Against HO-induced Oxidative Damage in HaCaT Cells.

Liu H, Xu P, Cheng M, Lei S, Liu Q, Wang W Molecules. 2021; 26(11).

PMID: 34198860 PMC: 8201020. DOI: 10.3390/molecules26113432.

References
1.
Meng X, Nikolic-Paterson D, Lan H . TGF-β: the master regulator of fibrosis. Nat Rev Nephrol. 2016; 12(6):325-38. DOI: 10.1038/nrneph.2016.48. View

2.
Song S, Zhang R, Cao W, Fang G, Yu Y, Wan Y . Foxm1 is a critical driver of TGF-β-induced EndMT in endothelial cells through Smad2/3 and binds to the Snail promoter. J Cell Physiol. 2018; 234(6):9052-9064. PMC: 6686160. DOI: 10.1002/jcp.27583. View

3.
Hata A, Chen Y . TGF-β Signaling from Receptors to Smads. Cold Spring Harb Perspect Biol. 2016; 8(9). PMC: 5008074. DOI: 10.1101/cshperspect.a022061. View

4.
De Rose V, Arduino C, Cappello N, Piana R, Salmin P, Bardessono M . Fcgamma receptor IIA genotype and susceptibility to P. aeruginosa infection in patients with cystic fibrosis. Eur J Hum Genet. 2004; 13(1):96-101. DOI: 10.1038/sj.ejhg.5201285. View

5.
Park E, Chun J, Kim S, Kim C, Lee H, Kim H . Schisandrin B suppresses TGFβ1 signaling by inhibiting Smad2/3 and MAPK pathways. Biochem Pharmacol. 2011; 83(3):378-84. DOI: 10.1016/j.bcp.2011.11.002. View